Avidity Biosciences, Inc. (RNA) Covered Calls

Avidity Biosciences, Inc. covered calls Prosensa Holding N.V. is engaged in the discovery and development of RNA-modulating therapeutics for the treatment of rare genetic disorders. Its lead product candidates includes drisapersen and PRO044.

You can sell covered calls on Avidity Biosciences, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for RNA (prices last updated Mon 12:25 PM ET):

Avidity Biosciences, Inc. (RNA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
24.76 +0.40 24.74 24.82 288K - 1.9
Covered Calls For Avidity Biosciences, Inc. (RNA)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 25 2.15 22.67 9.5% 183%
Jun 21 25 3.10 21.72 14.3% 96.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands.